99 related articles for article (PubMed ID: 8659199)
1. [Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?].
Schweizer J; Kaulen R; Altmann E; Nierade A; Nanning T
Z Kardiol; 1996 Mar; 85(3):193-7. PubMed ID: 8659199
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers and nitrates in patients with peripheral arterial occlusive disease: long-term findings.
Schweizer J; Kaulen R; Nierade A; Altmann E
Vasa; 1997; 26(1):43-6. PubMed ID: 9068264
[TBL] [Abstract][Full Text] [Related]
3. Vasodilating effects of celiprolol in patients with peripheral obliterative arterial disease.
Diehm C
J Int Med Res; 1988; 16 Suppl 1():34A-38A. PubMed ID: 2975611
[TBL] [Abstract][Full Text] [Related]
4. Different hemodynamic effects of celipropol and atenolol in patients with mild to moderate hypertension.
Saner H; Seiler A; Mahler F
Arzneimittelforschung; 1995 Jul; 45(7):790-5. PubMed ID: 8573224
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
[TBL] [Abstract][Full Text] [Related]
6. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease.
Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S138-44. PubMed ID: 2427845
[TBL] [Abstract][Full Text] [Related]
7. [Action of nitrates on pressure and volume in the peripheral circulation of patients with coronary heart disease and with peripheral arterial occlusive diseases].
Caesar K; Niemeyer H; Hossmann V; Saborowski F
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1738-41. PubMed ID: 347799
[No Abstract] [Full Text] [Related]
8. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
Dargie HJ; Grant S; McLenachan J
Am Heart J; 1991 Mar; 121(3 Pt 2):1017-20. PubMed ID: 1671726
[TBL] [Abstract][Full Text] [Related]
9. Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
Zoli M; Marchesini G; Brunori A; Cordiani MR; Pisi E
Hepatology; 1986; 6(6):1248-51. PubMed ID: 2878867
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness and duration of effect of molsidomine and isosorbide dinitrate in peripheral circulation].
König FK; Grewe R; Wörz K
Fortschr Med; 1985 Oct; 103(38):903-6. PubMed ID: 3908257
[No Abstract] [Full Text] [Related]
11. [The comparison of the efficacy of atenolol and isosorbide dinitrate therapy in chronic hypotension patients with stable angina pectoris].
Idrisova EM; Borovkova NV; Stepacheva TA; Chernov VI; Karpov RS
Klin Med (Mosk); 2001; 79(1):37-40. PubMed ID: 11234265
[TBL] [Abstract][Full Text] [Related]
12. Effect of atenolol and celiprolol on acetylcholine-induced coronary vasomotion in coronary artery disease.
Burger W; Hampel C; Kaltenbach M; Hartmann A; Herrmann M; Hoffmann JA; Klepzig H
Am J Cardiol; 2000 Jan; 85(2):172-7. PubMed ID: 10955372
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of celiprolol in essential hypertension.
Frohlich ED; Ketelhut R; Kaesser UR; Losem CJ; Messerli FH
Am J Cardiol; 1991 Aug; 68(5):509-14. PubMed ID: 1678580
[TBL] [Abstract][Full Text] [Related]
14. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of ischemic heart disease with beta-receptor blockers and isosorbide dinitrate (author's transl)].
Wermuth G
MMW Munch Med Wochenschr; 1975 Oct; 117(40):1613-4. PubMed ID: 241932
[TBL] [Abstract][Full Text] [Related]
16. [Coronary artery disease observed in general hospitals: ETTIC study. Comparison between trimetazidine and mononitrate isosorbide for patients receiving betablockers].
Hanania G; Haïat R; Olive T; Maalouf B; Michel D; Martelet M; Godard S;
Ann Cardiol Angeiol (Paris); 2002 Nov; 51(5):268-74. PubMed ID: 12515103
[TBL] [Abstract][Full Text] [Related]
17. Exercise metabolism in healthy volunteers taking celiprolol, atenolol, and placebo.
Head A; Maxwell S; Kendall MJ
Br J Sports Med; 1997 Jun; 31(2):120-5. PubMed ID: 9192124
[TBL] [Abstract][Full Text] [Related]
18. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
[TBL] [Abstract][Full Text] [Related]
19. [Effects of nitrates and beta-blockers on platelet aggregation in patients with coronary heart disease].
Wlazłowski R; Kruszyński G; Goch JH
Pol Merkur Lekarski; 2000 Feb; 8(44):77-9. PubMed ID: 10808734
[TBL] [Abstract][Full Text] [Related]
20. Silent myocardial ischemia: some good news.
Killip T
Circulation; 1997 Apr; 95(8):1992-3. PubMed ID: 9133504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
